Linking an early access program (EAP) to the National Health Data System (NHDS) in France and assessing its performances and potential biases

Representatives of the Artificial Intelligence & Cancers Association, the French National Cancer Institute and AstraZeneca were honored to present at ASCO 2024 the results of a first collaborative project demonstrating the proof-of-concept of matching early access data with data from the SNDS.

Back

Filière Intelligence Artificielle & Cancers

AMGEN | ariis| AstraZeneca | Bristol Myers Squibb | France Biotech | Health Data Hub | Institut national du cancer | JANSSEN | MSD | Novartis | Pfizer | Pierre Fabre | Roche Diagnostics

PariSanté Campus

2-10 rue d’Oradour-sur-Glane
75015 PARIS

Copyright © 2023 by mlcom. Tous les droits sont réservés.

Youtube Linkedin